Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer [Phase 3]
This entry reports a Phase 3 trial of UGN-103 for low-grade, intermediate-risk non-muscle invasive bladder cancer and indicates the study is…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
University of Washington is conducting a trial to collect blood and tissue samples from patients with locally recurrent or metastatic prosta…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
A Phase 1 dose-escalation study of UGN-301 in patients with recurrent non-muscle invasive bladder cancer has been completed.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study [NA]
A sequential mixed-methods intervention trial to support sexual health in bladder cancer patients, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Genetic Susceptibility to Bladder Cancer
Clinical trial update on genetic susceptibility to bladder cancer at MD Anderson Cancer Center; the trial is currently active but not recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) [Phase 1, Phase 2]
This clinical trial update reports on a phase 1/2 study of Intismeran Autogene (V940) with pembrolizumab for bladder cancer. The study is cu…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations [Phase 1, Phase 2]
Early-phase clinical update on TYRA-300 showing safety signals and preliminary anti-tumor activity in locally advanced or metastatic urothel…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial [NA]
A micro-randomized trial testing dosing of physical activity among older cancer survivors with chronic pain is currently recruiting. The tri…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Olfactive Detection of Urothelial Carcinoma by Sniffer Dogs
An ongoing clinical trial in Strasbourg is recruiting to evaluate whether trained sniffer dogs can detect urothelial carcinoma (bladder canc…
-
CLINICAL_TRIALS other · 2026-01-12Clinical Trial Update: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT [Phase 3]
Phase 3 trial evaluating adjuvant Cretostimogene Grenadanorepvec for intermediate-risk non-muscle invasive bladder cancer after TURBT is cur…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: 18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy [EARLY_Phase 1]
An early-phase trial update reports results for using 18F-fluciclovine PET/CT to stage muscle-invasive bladder cancer before radical cystect…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy in Advanced Urothelial Cancer.
This clinical trial update reports on the outcomes, tolerability, and costs of using avelumab as maintenance therapy and pembrolizumab as se…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Renal Retention in High Grade Upper Tract Urothelial Cancer [Phase 2]
A Phase 2 clinical trial at Johns Hopkins is recruiting to evaluate treatment for high-grade upper tract urothelial carcinoma and bladder ca…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
A clinical trial funded by Elephas is exploring a biomarker-based method to predict response to immunotherapy using live tumor biopsies; the…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm [NA]
This clinical trial update describes a study evaluating multi-parametric MRI for local staging in patients suspected of muscle-invasive blad…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer [Phase 1, Phase 2]
Update on a Phase II study evaluating Atezolizumab with cisplatin and gemcitabine as neoadjuvant therapy for bladder cancer; the trial is cu…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer [Phase 2]
A phase 2 study evaluating nivolumab as adjuvant therapy after chemo-radiation in localized muscle-invasive bladder cancer; the trial is cur…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Molecular Analysis Of Bladder Cancer
Clinical trial update for the molecular analysis of bladder cancer sponsored by Lahey Clinic; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Adaptive Radiotherapy for Genitourinary Cancers [NA]
Clinical trial update indicates ongoing recruitment for an adaptive radiotherapy study in genitourinary cancers, including prostate cancer a…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
An ongoing Beijing-based clinical trial evaluating an AI-based early warning system to screen for prostate and bladder cancer in men, curren…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer [Phase 1]
Pembrolizumab is being studied in a Phase 1 trial for muscle invasive and metastatic bladder cancer; the study is active but not currently r…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
Clinical trial update on Bladder CARE™, a non-invasive urine test designed to detect bladder cancer in inconclusive cases.
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer [Phase 2]
Phase 2 neoadjuvant trial of toripalimab in combination with gemcitabine for cisplatin-ineligible locally advanced urothelial carcinoma/blad…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection [Phase 2, Phase 3]
A completed Phase 2/3 trial from Ain Shams University investigated whether the osmolarity of postoperative irrigation fluids influences the …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration [Phase 2]
A Phase 2 clinical trial is exploring tremelimumab in combination with intravesical Bacillus Calmette-Guérin for high-risk non-muscle-invasi…